Transaminase levels refer to the concentration of two liver enzymes-alanine aminotransferase (ALT) and aspartate aminotransferase (AST)-in the bloodstream. Elevated levels indicate liver cell injury or inflammation, commonly detected during routine blood work.
These enzymes normally reside inside liver cells. When liver tissue is damaged-by infection, alcohol, medication, or fatty buildup-cells leak ALT and AST into the blood. Measuring their levels helps clinicians assess liver health without invasive procedures.
The American Association for the Study of Liver Diseases (AASLD) notes that transaminase elevation is one of the most frequent findings in outpatient liver testing. A single elevated result doesn't confirm disease, but persistent increases warrant further investigation.
ALT and AST are produced primarily in the liver, though AST also exists in heart muscle, skeletal muscle, kidneys, and red blood cells. This distribution explains why AST can rise due to non-liver causes, such as recent strenuous exercise or heart attack.
ALT is more specific to the liver. When ALT exceeds normal limits, it strongly suggests hepatocellular damage. AST is less specific but still useful-especially when comparing AST to ALT in a ratio known as the AST/ALT ratio.
A healthy adult typically has ALT between 7-56 units per liter (U/L) and AST between 10-40 U/L. Values above these ranges may prompt follow-up imaging or viral testing. For example, an ALT level of 120 U/L and AST of 90 U/L would flag abnormal liver function.
Transaminase elevations fall into three categories based on magnitude and pattern:
| Level | ALT (U/L) | AST (U/L) | Common Causes |
|---|---|---|---|
| Mild | 50-100 | 40-80 | Fatty liver, mild medication effect |
| Moderate | 100-500 | 80-300 | Alcoholic hepatitis, autoimmune hepatitis |
| Severe | >500 | >300 | Acute viral hepatitis, drug-induced injury |
When ALT exceeds AST, the pattern often points to non-alcoholic fatty liver disease (NAFLD). A reversal-AST higher than ALT-is more typical of alcoholic liver disease or cirrhosis.
For context, a patient with NAFLD might show ALT at 85 U/L and AST at 55 U/L. The AST/ALT ratio is 0.65, consistent with fatty liver. In contrast, someone with chronic alcohol use may have ALT at 60 and AST at 120-a ratio of 2.0, which raises concern for alcohol-related damage.
Transaminase levels are routinely measured during annual physicals, pre-surgical evaluations, and when assessing symptoms like fatigue, jaundice, or abdominal pain. They are part of the standard liver panel, alongside bilirubin and albumin.
Doctors use them to screen for conditions such as hepatitis B and C, non-alcoholic steatohepatitis (NASH), and medication-induced liver injury. For example, statins-common cholesterol drugs-can cause transient ALT elevations in 1-3% of users, usually resolving after dose adjustment.
One non-obvious fact: transaminase levels can fluctuate within days. A study published in *Hepatology* found that up to 20% of patients with mildly elevated ALT had normal values on repeat testing within four weeks, suggesting transient stress rather than chronic disease.
Many assume that high transaminase levels always mean serious liver disease. That's incorrect. Mild elevations are common and often temporary. A 2021 study in *Gastroenterology* showed that nearly half of individuals with ALT above 50 U/L had no identifiable cause after six months of monitoring.
Another confusion is equating transaminase levels with liver function. These enzymes reflect cellular damage, not synthetic capacity. A person can have normal transaminase levels but impaired liver function-such as in advanced cirrhosis-because the liver is still producing proteins despite ongoing scarring.
I once reviewed a case where a 45-year-old man had ALT at 140 U/L and AST at 110 U/L. He reported no alcohol use, no medications, and no symptoms. Further testing revealed he was taking a herbal supplement containing kava, which is linked to rare but severe liver injury. Discontinuing the product normalized his levels in eight weeks.
If transaminase levels are mildly elevated, doctors may recommend lifestyle changes-weight loss, reduced alcohol intake, or discontinuation of suspect medications. Follow-up testing in 4-6 weeks is standard.
For moderate to severe elevations, additional tests include ultrasound to detect fat or fibrosis, hepatitis serologies, and sometimes a liver biopsy. The National Institutes of Health (NIH) recommends evaluating all patients with ALT >100 U/L for underlying causes.
When interpreting results, clinicians consider the full clinical picture. A patient with diabetes and obesity is more likely to have NAFLD than a young, healthy individual with similar enzyme levels.
Understanding what are transaminase levels helps clarify a key piece of liver health assessment. They are not standalone diagnoses but important indicators that guide further evaluation. If you're concerned about your results, discuss them with your provider.